“Impact of the Addition of Daratumumab to the Standard Bortezomib-Thalidomide-Dexamethasone Regimen on Hematopoietic Stem Cell Mobilization and Collection, Post-Transplant Engraftment and Infectious Complications: A Case-Control Multicentre Real-Life Analy”. 2024. Mediterranean Journal of Hematology and Infectious Diseases 16 (1): e2024049. https://doi.org/10.4084/MJHID.2024.049.